|
8-K: Regulation FD Disclosure
On October 15, 2026, Ernexa Therapeutics Inc., a Delaware corporation (the “Company”, “we”, “us”, or “our”), made available a presentation for investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by r...
|